259 related articles for article (PubMed ID: 32850320)
1. Prognostic Value of the Platelet-to-Lymphocyte Ratio in Patients With Melanoma: A Meta-Analysis.
Zhang F; Gong W
Front Oncol; 2020; 10():1116. PubMed ID: 32850320
[No Abstract] [Full Text] [Related]
2. Platelet-lymphocyte ratio acts as an independent predictor of prognosis in patients with renal cell carcinoma.
Wang Z; Peng S; Wang A; Xie H; Guo L; Jiang N; Niu Y
Clin Chim Acta; 2018 May; 480():166-172. PubMed ID: 29462592
[TBL] [Abstract][Full Text] [Related]
3. Prognostic role of the platelet to lymphocyte ratio (PLR) in the clinical outcomes of patients with advanced lung cancer receiving immunotherapy: A systematic review and meta-analysis.
Zhou K; Cao J; Lin H; Liang L; Shen Z; Wang L; Peng Z; Mei J
Front Oncol; 2022; 12():962173. PubMed ID: 36059629
[TBL] [Abstract][Full Text] [Related]
4. Prognostic Significance of Pretreatment Neutrophil-to-Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio, or Monocyte-to-Lymphocyte Ratio in Endometrial Neoplasms: A Systematic Review and Meta-analysis.
Leng J; Wu F; Zhang L
Front Oncol; 2022; 12():734948. PubMed ID: 35651788
[TBL] [Abstract][Full Text] [Related]
5. Prognostic and clinicopathological significance of the platelet-to-lymphocyte ratio in melanoma: A meta-analysis involving 2099 patients.
Han SN; Feng SJ; Liu Y
Kaohsiung J Med Sci; 2021 Jan; 37(1):55-62. PubMed ID: 32783332
[TBL] [Abstract][Full Text] [Related]
6. Prognostic role of platelet to lymphocyte ratio in pancreatic cancers: A meta-analysis including 3028 patients.
Li W; Tao L; Lu M; Xiu D
Medicine (Baltimore); 2018 Feb; 97(8):e9616. PubMed ID: 29465553
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of platelet-to-lymphocyte ratio in urothelial carcinoma patients: a meta-analysis.
Bao Y; Wang Y; Li X; Pan M; Zhang H; Cheng Z; Wang X
Cancer Cell Int; 2019; 19():315. PubMed ID: 31798344
[TBL] [Abstract][Full Text] [Related]
8. Preoperative Neutrophil Lymphocyte Ratio Can Be Used as a Predictor of Prognosis in Patients With Adenocarcinoma of the Esophagogastric Junction: A Systematic Review and Meta Analysis.
Liu XB; Gao ZY; Zhang QH; Pandey S; Gao B; Yang F; Tong Q; Li SB
Front Oncol; 2020; 10():178. PubMed ID: 32154173
[No Abstract] [Full Text] [Related]
9. Prognostic impact of platelet-to-lymphocyte ratio on diffuse large B-cell lymphoma: a meta-analysis.
Chen Y; Zhang Z; Fang Q; Jian H
Cancer Cell Int; 2019; 19():245. PubMed ID: 31572062
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of platelet-to-lymphocyte ratio in patients with ovarian cancer: A meta-analysis.
Tian C; Song W; Tian X; Sun Y
Eur J Clin Invest; 2018 May; 48(5):e12917. PubMed ID: 29469190
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of platelet-to-lymphocyte ratio in non-small-cell lung cancer: a meta-analysis.
Qiang G; Liang C; Xiao F; Yu Q; Wen H; Song Z; Tian Y; Shi B; Guo Y; Liu D
Onco Targets Ther; 2016; 9():869-76. PubMed ID: 26955285
[TBL] [Abstract][Full Text] [Related]
12. Prognostic prediction of the platelet-to-lymphocyte ratio in hepatocellular carcinoma: a systematic review and meta-analysis.
Li DZ; Guo J; Song QK; Hu XJ; Bao XL; Lu J
Transl Cancer Res; 2022 Nov; 11(11):4037-4050. PubMed ID: 36523315
[TBL] [Abstract][Full Text] [Related]
13. Neutrophil to Lymphocyte Ratio and Platelet to Lymphocyte Ratio as Prognostic Predictors for Hepatocellular Carcinoma Patients with Various Treatments: a Meta-Analysis and Systematic Review.
Zheng J; Cai J; Li H; Zeng K; He L; Fu H; Zhang J; Chen L; Yao J; Zhang Y; Yang Y
Cell Physiol Biochem; 2017; 44(3):967-981. PubMed ID: 29179180
[TBL] [Abstract][Full Text] [Related]
14. Prognostic role of platelet to lymphocyte ratio in non-small cell lung cancers: A meta-analysis including 3,720 patients.
Zhao QT; Yuan Z; Zhang H; Zhang XP; Wang HE; Wang ZK; Duan GC
Int J Cancer; 2016 Jul; 139(1):164-70. PubMed ID: 26915723
[TBL] [Abstract][Full Text] [Related]
15. Platelet-lymphocyte ratio as a potential prognostic factor in gynecologic cancers: a meta-analysis.
Jiang S; Liu J; Chen X; Zheng X; Ruan J; Ye A; Zhang S; Zhang L; Kuang Z; Liu R
Arch Gynecol Obstet; 2019 Oct; 300(4):829-839. PubMed ID: 31385023
[TBL] [Abstract][Full Text] [Related]
16. Prognostic role of pretreatment platelet to lymphocyte ratio in urologic cancer.
Wang J; Liu Y; Zhang N; Li X; Xin P; Bi J; Kong C
Oncotarget; 2017 Sep; 8(41):70874-70882. PubMed ID: 29050328
[TBL] [Abstract][Full Text] [Related]
17. Prognostic role of platelet to lymphocyte ratio in esophageal cancer: A meta-analysis.
Zhao QT; Zhang XP; Zhang H; Duan GC
Oncotarget; 2017 Dec; 8(67):112085-112093. PubMed ID: 29340113
[TBL] [Abstract][Full Text] [Related]
18. [Meta-analysis of Platelet Lymphocyte Ratio as A Prognostic Factor for
Non-small Cell Lung Cancer].
Chen H; Xue H; Liu W; Wu F; Wang Y; Gao H
Zhongguo Fei Ai Za Zhi; 2019 May; 22(5):289-298. PubMed ID: 31109438
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the prognostic role of platelet-lymphocyte ratio in cancer patients treated with immune checkpoint inhibitors: A systematic review and meta-analysis.
Xu H; He A; Liu A; Tong W; Cao D
Int Immunopharmacol; 2019 Dec; 77():105957. PubMed ID: 31677498
[TBL] [Abstract][Full Text] [Related]
20. Systematic review and meta-analysis of the prognostic value of preoperative platelet-to-lymphocyte ratio in patients with urothelial carcinoma.
Wu S; Wan Q; Xu R; Zhu X; He H; Zhao X
Oncotarget; 2017 Oct; 8(53):91694-91702. PubMed ID: 29207678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]